See our current projects: NCN Grant awarded to Dr. Monika Anna Golińska for endometriosis and ovarian cancer research. We are excited to share that Dr. Monika Anna Golińska has been awarded the NCN "MSCA POLONEZ BIS 3" grant Importance of the NUDT16L1-TP53BP1-TP53 axis in obesity and type 2 diabetes Obesity is one of the main risk factors for the development of type 2 diabetes as it leads to excessive Decoding “metabolic memory” – how do glycemic control and variability affect epigenetic changes in young people with type 1 diabetes? Type 1 diabetes (T1D) is the most common metabolic disease in childhood. It is caused by the destruction of pancreatic Screening for mobilization failure during hematopoietic stem cell transplantation through non-coding RNA profiling. Transplantation of hematopoietic stem cells from bone marrow is a widely used method for treating various diseases, such as blood The role of proinsulin C-peptide and G-protein coupled receptor 146 (GPR146) – clinical observation of their signaling pathway’s impact on... The project aims to investigate the role of proinsulin C-peptide and G-protein coupled receptor 146 (GPR146) in type 2 diabetes Intrinsic tumour radiosensitivity as a marker of chemoradiotherapy-induced immunogenic effects in rectal cancer Colorectal cancer (CRC) is the second leading cause of cancer death in the world. Standard treatment of patients with locally Bob Bast’s Translational Research Grant 2022 We are happy to announce that our team, as the part of international collaboration with UK FOCSS and Dana Farber Two projects awarded Polish Diabetes Association research grants We are pleased to announce that the members of our team - Arkadiusz Michalak (PhD student at the Department of We will learn about immune contexture changes induced in lung cancers by chemo- and radiotherapy Zuzanna Nowicka, a graduate of the Faculty of Medicine at the Medical University of Lodz (2020) and our Individual Course LAMAinDiab – lisdexamphetamine vs methylphenidate [,,,] Medical Research Agency announced the results of the call for non-commercial clinical trials in psychiatry and neurology. We are pleased 1 2 Next »
